Nepal vs Uruguay: The number of people with susceptibility test result for rifampicin
Nepal
81.26
in 2021
Uruguay
80.19
in 2021
Nepal rank
92nd
Uruguay rank
93rd
The number of people with susceptibility test result for rifampicin over time
- Nepal
- Uruguay
How they compare
Nepal currently reports 81.26 against 80.19 in Uruguay, a difference of 1.07.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Uruguay ahead.
Nepal ranks 92nd and Uruguay ranks 93rd of 146 countries.
Uruguay has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Nepal | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 43.61 | 83.76 | 40.16 | Uruguay |
| 2020s | 70.59 | 80.16 | 9.57 | Uruguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Nepal or Uruguay?
- Nepal, at 81.26 against 80.19 in Uruguay as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Nepal and Uruguay?
- 1.07, with Nepal ahead.
- How many years of comparable data are there for Nepal and Uruguay?
- 5 years are reported by both, from 2017 to 2021.
- How do Nepal and Uruguay rank globally for the number of people with susceptibility test result for rifampicin?
- Nepal ranks 92nd and Uruguay ranks 93rd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.